In a large-sample genome sequencing study, for example, iCCA was classified into two types: proliferative, which indicates a worse prognosis and is characterized by increased activity in tumor proliferation signaling pathways; and inflammatory, which is characterized by enriched immune signals like interleukins and chemokines [168]. This evidence concerns the gene PRRT2 and neoplasm.